Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2007

View Archived Issues

Antigen Express and University of Rochester to collaborate on avian influenza vaccine

NCI initiates glycan-based biomarker R&D program for cancer detection

Nuvelo enrolls patients in phase III trial of 10 mg alfimeprase for CO

EKR Therapeutics acquires rights to DepoDur for treatment of postoperative pain

New antidiabetic agents divulged in recent patent literature

Gene Logic enters new drug repositioning and development agreements

Positive results for CollaGenex's phase II study of Col-118 for erythema

Recent GSK and sanofi-aventis patents divulge novel analgesic agents

Novel agents for treating HCV infection disclosed in recent Kurume University patent

New data on lacosamide for the treatment of pain

Neuroprotective activity of Cerebrolysin in transgenic mouse model of Alzheimer's

Genentech resubmits sBLA to FDA for Avastin combination therapy

ImClone's phase II study of IMC-1121B for renal cancer opens for enrollment

Implicit begins phase IIa trial of intranasal oglufanide disodium for HCV

Neurochem reports top-line results from phase III trial of tramiprosate

ReGen reports results of phase IIa study of antidormancy effects of zolpidem

Antiatherosclerotic mechanism of the antioxidants AGI-1095 and AGI-1067 elucidated

Bioequivalence achieved with pioglitazone, glimepiride co-therapy and combination tablets

Study points to CRF receptors as target for interstitial cystitis and overactive bladder

Silodosin improves storage and voiding dysfunction in benign prostatic hyperplasia

Experimental evidence points to besipirdine efficacy in urinary incontinence

D-4F attenuates cardiac allograft vasculopathy in a murine model

2-Acetamidoindoles identified at ICAgen as potent, selective KCNQ channel openers

Triazine-based antiinflammatory compounds in development at ProMetic

Merck discusses SAR data for series of selective MC4 receptor agonists at ACS

Potent, selective, orally available H3 antagonists prepared by Abbott neuroscience team

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...